Status:
COMPLETED
Predictive Value of Heart Rate Variability on Cardiorespiratory Events
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Post-immunisation Apnoea and Bradycardia of Prematurity (AOP)
Eligibility:
All Genders
3-28 years
Brief Summary
The aim of this study are to investigate whether heart rate variability (HRV) parameters derived from nonlinear time series analysis at five different time points have prognostic utility for assessing...
Eligibility Criteria
Inclusion
- Inclusion criteria for preterm infants:
- Gestational Age (GA) 22+0 to 31+6 weeks and/or birth weight 400 g to 1500 g
- Chronological age \> 7 days
- Written informed parental consent
- Inclusion criteria for term healthy control infants:
- GA 37 to 42 weeks, chronological age 3 to 28 days (beyond initial transition after birth)
- Hospitalised in the neonatal rooming-in unit of the University Children's Hospital Basel as healthy co-twin or healthy sibling, or neonate ready to be discharged home after reconvalescence from minor illness such as hyperbilirubinaemia
- Written informed parental consent
- Exclusion Criteria:
- Major congenital malformations including neuromuscular disorders, thoracic malformations, major cardiac malformation
- Lack of written informed parental consent
Exclusion
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 5 2022
Estimated Enrollment :
292 Patients enrolled
Trial Details
Trial ID
NCT04303494
Start Date
July 1 2018
End Date
November 5 2022
Last Update
April 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Basel UKBB, University of Basel
Basel, Switzerland, 4056